What is Myriad Genetics's change in accrued liabilities?

Myriad Genetics (MYGN) reported change in accrued liabilities of -$7.4M in Q1 2026.

How has Myriad Genetics's change in accrued liabilities changed year-over-year?

Myriad Genetics's change in accrued liabilities increased by 40.3% year-over-year, from -$12.4M to -$7.4M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Myriad Genetics MYGN Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Labcorp HoldingsLH

-$27.4M+84.3%

NeoGenomicsNEO

-$7M+69.5%

Natera, Inc.NTRA

$98.23M+477%

Fulgent Genetics, Inc.FLGT

-$2.12M+71.6%

Tempus AI, Inc.TEM

$5.26M+119%

Personalis, Inc.PSNL

-$426K+84.5%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's change in accrued liabilities?: Myriad Genetics (MYGN) reported change in accrued liabilities of -$7.4M in Q1 2026.
How has Myriad Genetics's change in accrued liabilities changed year-over-year?: Myriad Genetics's change in accrued liabilities increased by 40.3% year-over-year, from -$12.4M to -$7.4M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.